AbbVie On Pace For Record Closing High — Data Talk

AbbVie, Inc. (ABBV) is currently at $247.14, up $4.01 or 1.65%


--Would be new all-time closing high (Based on available data back to Dec. 10, 2012)

--Would be the first new record closing high since Oct. 1, 2025, when it closed at $244.38

--On pace for largest percent increase since June 25, 2026, when it rose 3.51%

--Currently up five consecutive days; up 14.16% over this period

--Longest winning streak since Jan. 27, 2026, when it rose for five straight trading days

--Best five day stretch since the five days ending Nov. 5, 2020, when it rose 16.14%

--Up 14.16% this week; best weekly performance since the week ending Jan. 26, 2018, when it rose 17.75%

--Up 13.52% month-to-date; on pace for best month since Feb. 2025, when it rose 13.67%

--Up 8.16% year-to-date

--Up 35.56% from 52 weeks ago (June 27, 2025), when it closed at $182.31

--Would be a new 52-week closing high

--Up 35.56% from its 52-week closing low of $182.31 on June 27, 2025

--Traded as high as $248.78; new all-time intraday high (Based on available data back to Dec. 10, 2012)

--Up 2.32% at today's intraday high


All data as of 9:40:23 AM ET


Source: Dow Jones Market Data, FactSet


(END) Dow Jones Newswires

June 26, 2026 09:58 ET (13:58 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center